Nemaura Medical Inc. (NMRD)
Stock Price:
$5.65 USD
0.16 (2.91%)
Updated Aug 11, 2020 12:12 PM EDT - Market open
Key Info
| Market Cap |
129.31M |
| Revenue (ttm) |
n/a |
| Net Income (ttm) |
-4.16M |
| Shares Out |
22.89M |
| EPS (ttm) |
-0.20 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Aug 11, 2020 |
| Last Price |
$5.65 |
| Previous Close |
$5.49 |
| Change ($) |
0.16 |
| Change (%) |
2.91% |
| Day's Open |
5.52 |
| Day's Range |
5.50 - 5.75 |
| Day's Volume |
15,505 |
| 52-Week Range |
2.50 - 16.50 |
More Stats
| Market Cap |
129.31M |
| Enterprise Value |
129.20M |
| Earnings Date (est) |
Nov 16, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
22.89M |
| Float |
8.02M |
| EPS (basic) |
-0.2 |
| EPS (diluted) |
-0.20 |
| FCF / Share |
-0.18 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
112,370 |
| Short Ratio |
1.48 |
| Short % of Float |
2.52% |
| Beta |
-0.51 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
n/a |
| PB Ratio |
328.10 |
| Revenue |
n/a |
| Operating Income |
-4.78M |
| Net Income |
-4.16M |
| Free Cash Flow |
-3.66M |
| Net Cash |
106,107 |
| Net Cash / Share |
0.00 |
| Gross Margin |
n/a |
| Operating Margin |
n/a |
| Profit Margin |
n/a |
| FCF Margin |
n/a |
| ROA |
-99.82% |
| ROE |
-910.37% |
| ROIC |
n/a |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (1)
| Buy |
1 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
14.0
Current: $5.65
High
14.0
Target: 14.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|
| Revenue | - | - | - | - | - | - | - | - |
| Operating Income | -4.78 | -4.48 | -1.91 | -1.55 | -1.54 | -1.32 | -0.59 | -0.83 |
| Net Income | -4.16 | -4.45 | -1.82 | -1.55 | -1.54 | -1.32 | -0.59 | -0.83 |
| Shares Outstanding | 20.81 | 18.09 | 15.01 | 20.50 | 20.17 | 20.00 | 18.53 | 18.00 |
| Earnings Per Share | -0.20 | -0.25 | -0.10 | - | - | -0.10 | - | - |
| Operating Cash Flow | -3.45 | -3.56 | -2.14 | -1.19 | -1.21 | -1.43 | 1.50 | -0.77 |
| Capital Expenditures | -0.21 | -0.08 | -0.05 | -0.08 | -0.01 | -0.02 | - | -0.03 |
| Free Cash Flow | -3.66 | -3.64 | -2.18 | -1.27 | -1.22 | -1.45 | 1.50 | -0.80 |
| Cash & Equivalents | 0.11 | 3.74 | 5.73 | 7.14 | 9.40 | 0.35 | 1.96 | 0.20 |
| Net Cash / Debt | 0.11 | 3.74 | 5.73 | 7.14 | 9.40 | 0.35 | 1.96 | 0.20 |
| Assets | 1.22 | 4.76 | 6.26 | 7.40 | 9.73 | 0.91 | 2.05 | 0.26 |
| Liabilities | 2.53 | 2.54 | 2.14 | 2.04 | 2.05 | 1.83 | 1.68 | - |
| Book Value | -1.31 | 2.23 | 4.11 | 5.37 | 7.68 | -0.92 | 0.37 | 0.26 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Nemaura Medical Inc. |
| Country |
United States |
| Employees |
17 |
| CEO |
Dewan Fazlul Hoque Chowdhury |
Stock Information
| Ticker Symbol |
NMRD |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: NMRD |
Description
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.